Product Details
C-Reactive Protein / Serum Amyloid Protein Combined Detection
Clinical Significance (CRP/SAA)
Combined detection of CRP and SAA
"New three routine tests", namely white blood cell (WBC)+
C-reactive protein (CRP)+ serum amyloid A(SAA), were proposed by A
number of well-known pediatric experts in recent years based on the
clinical value of SAA detection in the diagnosis of infantile
infection, and have been widely used and recognized. The results
showed that the total positive rate of SAA in various inflammatory
diseases was 8.54% higher than that of CRP. Combined SAA and CRP
tests allow for more accurate diagnosis of the type of infection
and monitoring of the course of infectious disease
CRP / SAA performance index
Detection range | sample size | Sample type | Test time |
CRP | SAA | 5μl | Whole blood / serum / plasma | 3min |
0.5~200mg/L | 5~200mg/L |
Clinical significance of CRP / SAA
SAA normal CRP was normal | SAA normal Elevated CRP | SAA increased CRP was normal | SAA increased Elevated CRP |
Consider non infectious factors | The disease is improving | Consider virus infection | Consider bacterial infection |
Continue treatment according to clinical symptoms or continue to
monitor SAA, CRP until normal | Continue treatment according to clinical symptoms or continue to
monitor SAA, CRP until normal | Antiviral therapy; Monitor SAA and CRP until normal or consider
changing treatment plan | Antibiotic treatment, monitoring SAA, CRP to return to normal or
consider changing treatment regimens |
- Effectively evaluate the severity of virus infection
- Evaluate the therapeutic effect of viral infection
- Guide the rational use of antibiotics
Application Department
Laboratory, infection, fever clinic, pediatrics, cardiology, organ
transplantation, etc
Clinical comparison of CRP / SAA
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, microbial series,
biochemical series and immune series reagents and supporting
instruments.
The company has always adhered to the core concept of "fast and
accurate, living up to life", committed to providing society with
excellent products and services, and contributing to the cause of
human health.
Company Profile
Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is
located in Dingluan Industrial Zone, Changyuan City, Henan
Province. The company covers an area of about 100 acres and the
initial investment is about 200 million yuan. The company has a
scientific and complete management system, a purification workshop
of national standards, and a fully functional inspection center. On
this basis, the company will continue to invest in research and
development, accumulate technical strength, update manufacturing
equipment, improve production technology, improve inspection
technology, improve product quality, and provide customers with
safe and effective in vitro diagnostic products.
Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise
engaged in the research and development, production and operation
of in vitro diagnostic products. The in vitro diagnostic products
developed by the company cover POCT series, immune series,
microbial series and other reagents and supporting instruments.
The company has always adhered to the core concept of “fast and
accurate, living up to life”, committed to providing society with
excellent products and services, and contributing to the cause of
human health.